DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Bethesda North Marriott Hotel and Conference Center

2018 年 02 月 05 日 7:00 上午 - 2018 年 02 月 07 日 3:00 下午

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Regulatory Submissions, Information, and Document Management Forum

Session 6 Track 4: eCTD AdPromo Panel Discussion

Session Chair(s)

Thomas  Noto

Thomas Noto

Senior Director, Regulatory Operations

Lexicon Pharmaceuticals, United States

Although the eCTD AdPromo Guidance from the FDA has been out for more than two years, the majority of companies haven’t switched this process to eCTD. Commonly heard excuses are that it is complicated, expensive, and just too hard to change a process that entails hundreds of submissions a year per marketed product. This session will be an informative and fun panel discussion with seasoned experts who have made the switch to submitting AdPromo materials in eCTD format within their own companies, and lived to tell about it.

Learning Objective :

At the conclusion of this session, participants should be able to:

  • Understand the process of submitting AdPromo materials in eCTD
  • Anticipate the challenges to changing from a legacy process
  • Gain perspective into all AdPromo stakeholders in and their perspectives on what’s important
  • Speaker(s)

    Thomas  Noto

    Speaker

    Thomas Noto

    Lexicon Pharmaceuticals, United States

    Senior Director, Regulatory Operations

    Thomas  Christensen, RAC

    Speaker

    Thomas Christensen, RAC

    SynteractHCR, United States

    Senior Regulatory Affairs Manager

    Josephine  Secnik, MBA, MS

    Session 6 Track 4: eCTD AdPromo Panel Discussion

    Josephine Secnik, MBA, MS

    Eli Lilly and Company, United States

    Director – Ad/Promo Regulatory Affairs

    获得信息并保持参与

    不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。